跳至主要内容
临床试验/NCT01930981
NCT01930981已完成不适用

Prospective Assessment of Associations Between Pre-transplant Comorbidities and Post-transplant Toxicities and Quality of Life

Fred Hutchinson Cancer Center1 个研究点 分布在 1 个国家目标入组 252 人开始时间: 2012年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
252
试验地点
1
主要终点
The EQ-5D

研究概览

简要总结

We are interested in studying whether and how medical problems other than primary cancer before hematopoietic cell transplantation would impact the profiles of quality of life and toxicities post-transplantation for patients with blood cancers. We want to see if by assessing comorbidities (such as diabetes) early on, we can identify those patients who will have more toxicities or limitations in their quality of life after transplant. The generated information could set the stage for future intervention studies aiming to improve quality of life for patients with blood cancers after transplantation.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Prospective

入排标准

年龄范围
19 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Allogeneic HCT candidates who are >18 years of age
  • Able to speak and read English
  • Able to provide informed consent
  • Access to a telephone for study-related communications
  • Diagnosed with a hematological malignant disease
  • Willing to complete survey packets at 5 time-points, spanning two years

排除标准

  • HCT candidates who are 18 years or younger at the time of study enrollment
  • HCT candidates who cannot read, write, or speak English
  • Patients with diagnoses of non-malignant diseases, or solid tumors are primary disease

结局指标

主要结局

The EQ-5D

时间窗: Change from Baseline in Symptoms at 3,6,12,and 24 months

This measure is used to measure utilities that can be used to calculate a quality adjusted survival score.

The Cancer and Treatment Distress Scale

时间窗: Change from Baseline in Symptoms at 3,6,12,and 24 months

This is a 25-item scale assessing distress related to perceived demands from events specific to cancer survivors.

The MD Anderson Symptom Inventory

时间窗: Change from Baseline in Symptoms at 3,6,12,and 24 months

A 19-item instrument, it assesses physical symptoms and their interference with life.

The Social Activity Log

时间窗: Change from Baseline in Symptoms at 3,6,12,and 24 months

This measure captures the frequency and diversity of social activities outside of daily responsibilities.

ENRICHD Social Support Instrument

时间窗: Change from Baseline in Symptoms at 3,6,12,and 24 months

This measures social support, including participation in social activities and perception of social support.

The Patient Health Questionnaire-9

时间窗: Change from Baseline in Symptoms at 3,6,12,and 24 months

The PHQ-9 measures measures depression and parallels the nine diagnostic symptom criteria of the DSM-IV for Major Depressive Disorder.

The Functional Assessment of Cancer Therapy Bone Marrow Transplant Scale

时间窗: Change from Baseline in Symptoms at 3,6,12,and 24 months

A 49-item questionnaire measuring quality of life in bone marrow transplant patients, it measures physical, functional, social/family and emotional well-being in addition to bone marrow transplant-specific concerns.

次要结局

  • National Cancer Institute's Common Terminology Criteria for Adverse Events (NCI CTCAE)(at 90 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验